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Background. Data on cardiac and vascular structure in second-
ary hypertension are generally scarce, and no data on the inter-
relations between cardiac mass and structural characteristics of
the vessel wall, both in large and in small resistance arteries, are
presently available.
Objectives. The aim of this study was to investigate the relation
between structural changes in subcutaneous small arteries, left
ventricular mass and wall thickness of the common carotid artery
in patients with primary and secondary hypertension.
Methods. Seventy-four subjects were included in the study: 11
patients with pheochromocytoma, 14 with primary aldosteronism
(PA), 19 with renovascular hypertension (RVH), 18 with essential
hypertension (EH) and 12 normotensive (NT) control subjects. All
subjects were submitted to a biopsy of subcutaneous fat. Morpho-
logic characteristics of subcutaneous small resistance arteries
(relaxed diameter <300 mm) were directly evaluated using a
micromyographic technique. All subjects were submitted to cal-
culation of left ventricular mass index (LVMI) and common
carotid artery intima-media thickness (CCIMT), using ultra-
sound technique.
Results. The correlation coefficients between the media to
lumen ratio in subcutaneous small arteries (M/L) and LVMI or
between M/L and CCIMT were closer in RVH than in pheochro-
mocytoma, EH or NT; in PA the correlation coefficients were
slightly less close than those in RVH. An excess prevalence of
carotid plaques in RVH was observed.
Conclusions. A close relation between small resistance artery
morphology and cardiac or carotid artery structure may be
observed in those hypertensive patients in whom the renin-
angiotensin-aldosterone system is activated. In constrast, in NT,
EH and pheochromocytoma no significant correlation between
M/L and LVMI or CCIMT was observed.
(J Am Coll Cardiol 1998;32:985–92)
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Arterial hypertension is frequently associated with the pres-
ence of structural alterations in the heart, carotid artery and
small resistance arteries. The presence of left ventricular
hypertrophy (LVH), an increased thickness of carotid artery
walls or a greater media to lumen ratio (M/L) in small
resistance arteries may be extremely important in hyperten-
sion, both from a pathophysiologic and a clinical prognostic
point of view (1–3). Whether the cardiovascular changes are a
cause or a consequence of hypertension remains controversial,
however (4–6).
Vascular and cardiac structure may be influenced by circu-
lating, autocrine or paracrine hormonal factors. Patients with
secondary forms of hypertension are characterized by an
abnormal increase in the production of some neurohumoral
factors, such as angiotensin II, aldosterone or catecholamines,
all of which have been demonstrated to be able to stimulate
smooth muscle cell growth in vitro (7,8). Recent data suggest
that patients with renovascular hypertension (RVH) may have
an increased prevalence of LVH (9,10) and carotid artery
lesions (11), as well as more evident alterations in small
resistance arteries (12), as compared with patients with
pheocromocytoma or essential hypertension (EH). Also, pa-
tients with primary aldosteronism (PA) seem to be character-
ized by more evident cardiovascular structural alterations
(9,12–15). Patients with pheochromocytoma seem to present a
pattern of cardiovascular structural alterations similar to those
usually observed in patients with EH (9,16). In a previous study
we demonstrated that structural alterations observed in sub-
cutaneous small resistance arteries of patients with RVH could
be ascribed, at least in part, to smooth muscle cell growth,
whereas in patients with EH and those with pheochromocy-
toma, the vascular structural alterations can be almost entirely
explained by eutrophic remodeling (12). However, data on
cardiac and vascular structure in secondary hypertension are
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generally scarce, and no data on the interrelations between
cardiac mass and structural characteristics of the vessel wall,
both in large and in small resistance arteries, are presently
available.
Therefore, we considered it worthwhile to investigate the
relations between subcutaneous small resistance arteries, car-
diac mass and wall thickness of the common carotid artery in
patients with primary and secondary hypertension, as well as in
normotensive (NT) control subjects, using reliable minimally
invasive or noninvasive techniques. Our working hypothesis
was the following: if the growth factors exert a key role in the
genesis of cardiovascular structural alterations, then a closer
correlation between cardiac mass and vascular structural
changes should be observed in those patients showing in-
creased circulating or tissue levels of growth factors, such as
angiotensin II, aldosterone or catecholamines, as compared
with NT control subjects and patients with EH.
Methods
Patient group. Seventy-four subjects were included in the
study. Forty-four patients had a secondary form of hyperten-
sion: 11 had a pheochromocytoma, 14 had PA and 19 had
RVH. Data were compared with those obtained in 12 NT
subjects and in 18 patients with EH. Hypertensive patients had
a clinic blood pressure (average of three different sphygmoma-
nometric measurements, each performed on three separate
days, after a washout period of at least 2 weeks if previously
treated with antihypertensive drugs) .140/90 mm Hg. NT
control subjects had a systolic blood pressure ,140 mm Hg
and a diastolic blood pressure ,90 mm Hg. All hypertensive
patients had been previously treated for various periods of
time with calcium channel blockers, angiotensin-converting
enzyme inhibitors, diuretic agents or beta-blockers. There was
no statistically significant difference in the therapeutic regi-
mens of the different groups.
Venous blood samples were taken with the participants in
the supine position, after a washout period of at least 2 weeks,
for measurement of plasma renin activity (radioimmunoassay
Renctk, Sorin Biomedica, Turin, Italy), plasma and urinary
aldosterone (radioimmunoassay Aldoctk, Sorin Biomedica,
Turin, Italy), as well as plasma or urinary norepinephrine and
epinephrine (high performance liquid chromatography) (17).
The diagnosis of secondary forms of hypertension was made
on the basis of an indication for renal artery revascularization
(n 5 19) or adrenal tumor resection (n 5 21), after proper
investigation by imaging techniques and humoral assessments.
In one case a bilateral renal artery stenosis was demonstrated
by angiography, but the patient refused intervention. In four
cases a bilateral adrenal hyperplasia associated with high
plasma and urinary aldosterone levels was demonstrated. In
these cases no surgical correction was performed. Thirty-eight
patients had surgical repair or renal artery angioplasty, and
their hypertension was cured, except for four patients with
RVH whose blood pressure was significantly reduced, but
antihypertensive monotherapy was still required after 6
months. All these patients were previously placed on a combi-
nation therapy (three or four drugs). EH was diagnosed on the
basis of persistently elevated levels of blood pressure, after
careful exclusion of secondary causes.
Micromyography. All participants underwent a biopsy of
subcutaneous fat from the gluteal or anterior abdominal
region. The biopsy of the abdominal subcutaneous fat was
taken during a surgical procedure (usually a cholecystectomy
in NT subjects and patients with EH or an adrenalectomy or a
vascular surgical intervention on the renal arteries in patients
with secondary hypertension). In the remaining cases a stan-
dard skin biopsy of the gluteal region (3 cm long, 0.5 cm wide,
1.5 cm deep) was performed (18,19). The percentage of skin
biopsies taken from the abdomen was similar in the five groups
of subjects (;20% to 25%). We have previously demonstrated
that no difference in the morphology of small resistance
arteries obtained from the subcutaneous fat taken from the
gluteal or anterior abdominal region could be observed (12).
The protocol of the study was approved by the Ethics
Committee of our institution (Medical School, University of
Brescia), and written informed consent was obtained from
each participant. The procedures followed were in accordance
with institutional guidelines.
Small arteries (;160 to 280 mm average diameter in relaxed
conditions, 2 mm long) were dissected from the subcutaneous
fat of the biopsies and mounted as a ring preparation on an
isometric myograph (410 A, JP Trading, Aarhus, Denmark), by
threading onto two stainless-steel wires (40 mm diameter). The
two wires were attached to a force transducer and micrometer,
respectively, as previously described by Mulvany et al. (20,21).
Vessels were warmed to 37°C and allowed to equilibrate for at
least 30 min in physiologic saline solution with the following
composition (in mmol/liters): NaCl 119, NaHCO3 24, KCl 4.7,
KH2PO4 1.18, MgSO4 1.17, CaCl2 2.5 and glucose 5.5—kept
constantly at 37°C and bubbled with 5% carbon dioxide and
oxygen. The vessel internal circumference was set to give a wall
tension of 0.1 mN/mm.
Vessel wall and media thicknesses were measured at 12
sites, which were then averaged, using a light microscope with
immersion lens (Lab 20, Carl Zeiss S.P.A., Milan, Italy) at
3600 magnification, which provides a resolution of 0.2 mm.
Lower magnification was used for measurement of the distance
between the wires and length of the blood vessel. The rest
tension–internal circumference relation was determined, and
Abbreviations and Acronyms
CCIMT 5 common carotid artery intima-media thickness
EH 5 essential hypertension
LVH 5 left ventricular hypertrophy
LVMI 5 left ventricular mass index
M/L 5 media to lumen ratio in subcutaneous small arteries
NT 5 normotensive or normotension
PA 5 primary aldosteronism
RVH 5 renovascular hypertension
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vessels were set to the normalized circumference L1, where
L1 5 0.9 L100 and L100 5 the internal circumference the vessels
would have had in vivo, when relaxed and under a transmural
pressure of 100 mm Hg, as described previously by Mulvany et
al. (20,21). From L1, the normalized internal diameter, l1, was
calculated. Assuming that the cross-sectional area remains
constant when the vessel is extended to L1, the wall and media
thicknesses were automatically calculated also in normalized
condition. Wall and media thicknesses, as well as the M/L of
blood vessels in normalized condition (vessels extended to L1),
were obtained assuming a constant wall and media volume,
from wall and media cross-sectional areas calculated from wall
and media thicknesses measured in unstretched vessels, as
previously described (20,21). The average values obtained
from two vessels in each experiment were considered. For
further details see also references 22 and 23.
Echocardiography. In 11 patients with pheochromocy-
toma, 14 with PA, 19 with RVH, 18 with EH and 12 NT control
subjects, a standard echocardiographic evaluation (HP Sonos
1000 or 1500, Hewlett Packard) was performed. Echocardio-
graphic studies were performed in the morning, with the
subject in supine left lateral decubitus position, after 30 min of
rest. Only two physicians were responsible for recording the
echocardiograms. Echocardiographic tracings were of good
technical quality and were recorded on light-sensitive paper at
a paper speed of 50 mm/s. Two-dimensional imaging of the
longitudinal parasternal view was checked to avoid angulation
of the ultrasonic beam, and consequent changes in the left
ventricular shape. Left ventricular internal dimensions and left
ventricular posterior wall and interventricular septum thick-
nesses, were measured according to the recommendations of
the American Society of Echocardiography (24). Left ventric-
ular volumes were calculated using to the cube formula. Left
ventricular mass was calculated according to the Penn Con-
vention (25) and indexed to body surface area, calculated by
the formula of Dubois and Dubois (26). LVH was considered
present if the left ventricular mass index (LVMI) exceeded
110 g/m2 in women and 131 g/m2 in men (27,28).
Echocardiographic tracings were calculated blindly by two
expert independent readers, and the average measurements
were considered. Intraobserver and interobserver coefficients
of variation of measurements for LVMI in both NT subjects
and hypertensive patients were 8.2 and 9.2%, respectively. For
further details on the methods used, see references 3, 29 and
30.
Carotid ultrasound. In 11 patients with pheochromocy-
toma, 12 with PA, 14 with RVH, 17 with EH and 11 NT control
subjects, B-mode imaging of the carotid arteries was obtained
using a Hewlett Packard Sonos 1000 or 1500 echocardio-
graphic unit equipped with a 7.5-MHz imaging transducer. The
subjects were studied lying in the supine position, with slight
hyperextension of the neck, and the common carotid artery,
the carotid bifurcation and the extracranial portions of internal
and external carotid arteries were identified. The average
duration of the scanning was 30 min, and the entire scanning
procedure was recorded on a 1⁄2-in. super VHS videotape. All
carotid measurements were subsequently performed by two
independent readers who had no knowledge of the subjects’
identity, echocardiographic measurements and risk factors,
and average values were considered; VCR recordings of the
entire scanning were analyzed using the measure morphometry
software of the echocardiographic unit.
Measurements included end-diastolic (minimal diameter)
intima-media thickness of the far walls (distance from the
leading edge of the first echogenic line to the leading edge of
the second echogenic line), as described previously by Pignoli
et al. (31). Several measures were obtained in each arterial
segment (6 to 12), according to a previously described protocol
(32–34), and the mean value of all measurements on the far
wall for each segment was calculated. The thickness of the
intima-media layers was measured at end-diastole and the
mean maximal value was calculated in at least six points—in
the left and right common carotid artery, carotid bifurcation
and internal carotid artery. Wall thickness in the carotid artery
was never measured at the level of a discrete plaque.
The interobserver and intraobserver coefficients of varia-
tion for measurements of intima-media thickness in our labo-
ratory is 7.6% and 6.9%, respectively (3), comparable with
those reported by Salonen et al. (35).
Definitions of early atherosclerotic lesions for studies that
use B-mode imaging to study the artery wall are variable, and
several criteria for defining normal walls, intima-media thick-
ening and plaque have been proposed (32–34,36). In this study,
the criteria of Salonen et al. (36) were applied: a normal wall
was considered when intima-media thickness was ,1 mm;
carotid wall thickening was considered when intima-media
thickness was .1 mm; and a plaque was considered in the
presence of wall thickening either with mineralization or with
focal protrusion in the lumen at least 50% greater than the
surrounding wall (usually .2 mm).
Statistical analysis. All data are expressed as the mean
value 6 SD, unless otherwise stated. One-way analysis of
variance was used to evaluate differences among groups. The
relation between continuous variables was evaluated by linear
regression. A separate analysis of subgroups, with a test of
equality of lines (difference in slopes and/or intercepts) across
groups, was performed. Differences in the incidence of carotid
plaques among groups were evaluated by the chi-square test
and the Fisher exact test. All analyses were carried out with the
BMDP statistical package (BMDP software programs 7D, 1V
4F and 1R, BMDP Statistical Software Inc.). In consideration
of the multiple comparisons performed, we have adopted a
conservative approach, and therefore the significance levels
was set at 1%.
Results
The five groups of subjects did not differ by age (Table 1),
serum lipids or smoking habits. Systolic and diastolic blood
pressures were similar in the four groups of hypertensive
patients, although there was a small, although not significant,
tendency to greater values in patients with RVH (Table 1). The
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known duration of hypertension was about 3 to 4 years in all
hypertensive groups.
Humoral data. A statistically significant increase in plasma
and urinary norepinephrine was observed in patients with
pheochromocytoma, as compared with NT subjects and pa-
tients with EH (Table 1). Plasma renin activity was increased in
patients with RVH and was reduced in patients with PA, as
compared with the remaining groups (Table 1). Plasma and
urinary aldosterone levels were significantly increased in pa-
tients with PA, whereas only plasma aldosterone significantly
increased in patients with RVH.
Morphology of small subcutaneous resistance arteries. In
comparison with NT subjects, the M/L ratio was significantly
increased in all hypertensive patients. In patients with PA and
those with RVH the increase in the M/L ratio was more
pronounced. In addition, the difference between values ob-
tained in these patients and values obtained in patients with
pheochromocytoma and those with EH was statistically signif-
icant (Table 2). The normalized internal diameter was signif-
icantly smaller in patients with PA and those with RVH, as
compared with NT control subjects (Table 2).
Cardiac structure. LVMI, calculated according to the
Penn Convention, was significantly greater in patients with EH
and in those with RVH than in NT control subjects (Table 2).
The percentage of patients with LVH was 36% in patients with
pheochromocytoma, 29% in those with PA, 68% in those with
RVH and 39% in those with EH. LVH was never observed in
normotensive controls.
The septal thickness was greater in patients with EH and
those with RVH than in NT control subjects. The posterior
wall thickness was significantly greater in patients with RVH
and those with PA than in NT control subjects. In addition, in
Table 1. Demographic and Clinical Data in the Different Groups
Variable
Pheo
(n 5 11)
PA
(n 5 14)
RVH
(n 5 19)
EH
(n 5 18)
NT
(n 5 12)
Age (years) 49 6 23 52 6 13 55 6 11 55 6 6 54 6 14
Gender (M/F) 5/6 4/10 10/9 11/7 6/6
Weight (kg) 63 6 14 69 6 14 67 6 11 69 6 10 69 6 11
Height (cm) 163 6 9 163 6 6 166 6 8 168 6 9 164 6 14
Body surface area (m2) 1.74 6 0.21 1.80 6 0.15 1.80 6 0.16 1.82 6 0.15 1.81 6 0.18
Systolic blood pressure (mm Hg) 159 6 19* 169 6 28* 171 6 22* 161 6 7* 128 6 8
Diastolic blood pressure (mm Hg) 99 6 20* 104 6 9† 106 6 13* 98 6 7* 79 6 7
Plasma renin activity (ng/ml per h) NA 0.21 6 0.27‡ 8.75 6 8.67†‡ 1.1 6 1.0 0.9 6 1.1
Plasma aldosterone (pmol/ml) NA 1.12 6 0.58† 1.01 6 0.77† 0.42 6 0.31 0.30 6 0.26
Urinary aldosterone (nmol/24 h) NA 289 6 192† 184 6 142 31.0 6 22.0 36.3 6 25.4
Plasma norepinephrine (nmol/liters) 26.9 6 29.5† NA NA 2.6 6 3.0 2.2 6 2.2
Plasma epinephrine (nmol/liters) 14.8 6 16.5 NA NA 0.51 6 0.61 0.43 6 0.52
Urinary norepinephrine (nmol/24 h) 4,450 6 4,298†§ 151 6 57 140 6 93 333 6 284 261 6 251
Urinary epinephrine (nmol/24 h) 313 6 403 35 6 43 67 6 88 82 6 77 67 6 74
Serum cholesterol (mmol/liters) 5.1 6 0.83 5.3 6 1.50 5.5 6 1.09 5.6 6 1.21 5.1 6 1.58
Serum triglycerides (mmol/liters) 1.4 6 0.51 1.2 6 0.56 1.6 6 0.87 1.7 6 0.82 1.5 6 0.70
*p , 0.001 and †p , 0.01 compared with normotensive control subjects. ‡p , 0.01 and §p , 0.001 compared with patients with essential hypertension. Data are
presented as the mean value 6 SD. EH 5 patients with essential hypertensive; NA 5 data not available; NT 5 normotensive control subjects; PA 5 patients with
primary aldosteronism; Pheo 5 patients with pheochromocytoma; RVH 5 patients with renovascular hypertension.
Table 2. Morphologic Characteristics of Patients With Primary and Secondary Hypertension as Well as in Normotensive Control Subjects
Pheo PA RVH EH NT
Small resistance vessel data
Media/lumen ratio 0.080 6 0.020* 0.105 6 0.028* 0.130 6 0.045*‡¶ 0.093 6 0.023* 0.058 6 0.01
Media thickness (mm) 19.9 6 6.34 21.6 6 4.8 25.2 6 7.1 22.9 6 4.22 19.6 6 5.91
Internal diameter (mm) 254 6 59 220 6 81† 217 6 80† 258 6 67 312 6 72
Echocardiographic data
Left ventricular mass index (g/m2) 115 6 39 105 6 27 130 6 27* 120 6 24† 92 6 25
Relative wall thickness (mm) 0.40 6 0.04 0.43 6 0.07† 0.43 6 0.07† 0.36 6 0.07 0.32 6 0.11
Posterior wall thickness (mm) 0.85 6 0.14 0.90 6 0.15† 0.96 6 0.15*‡ 0.83 6 0.13 0.77 6 0.06
Septum thickness (mm) 0.99 6 0.18 0.99 6 0.17 1.06 6 0.16* 1.09 6 0.2* 0.85 6 0.09
Carotid artery data
Common carotid artery intima-media thickness (mm) 0.86 6 0.24 0.77 6 0.21 0.98 6 0.29† 0.80 6 0.17 0.70 6 0.14
Carotid bifurcation intima-media thickness (mm) 1.25 6 0.43 0.85 6 0.28 1.37 6 0.62 1.08 6 0.29 0.96 6 0.24
Internal carotid artery intima-media thickness (mm) 0.88 6 0.43 0.64 6 0.12 0.99 6 0.5 0.81 6 0.22 0.74 6 0.22
*p , 0.001 and †p , 0.01 compared with normotensive control subjects. ‡p , 0.01 compared with patients with essential hypertension. ¶p , 0.001 compared with
patients with pheochromocytoma. Data are presented as the mean value 6 SD. Abbreviations as in Table 1.
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patients with RVH the posterior wall thickness was signifi-
cantly greater than that in patients with EH. No difference in
relative wall thickness was observed among the various groups
of patients (Table 2).
Carotid artery structure. The common carotid artery
intima-media thickness (CCIMT) was significantly greater in
patients with RVH than in patients with EH and NT control
subjects (Table 2). Data for carotid bifurcation and internal
carotid artery intima media-thickness are reported in Table 2.
There was an excess prevalence of plaques in patients with
RVH and possibly also in patients with pheochromocytoma, as
compared with patients in the other groups (Table 3).
Linear regression analysis. The correlation coefficients
between the M/L ratio, LVMI and CCIMT are reported in
Table 3. In patients with RVH, the correlation between the
M/L ratio, LVMI and CCIMT was closer than in the other
groups (Figs. 1 and 2). There was a significant difference in the
slope or intercepts of the regression lines between patients
with renovascular hypertension and the remaining groups of
subjects (Table 4, Figs. 1 and 2).
One of the patients with RVH showed very high values of
M/L ratio, LVMI and CCIMT. To evaluate the effect of this
single patient on the regression outcome, we have recalculated
the correlation coefficient values without the “outlier.” A
modest reduction in the correlation coefficient was observed
(M/L ratio–LVMI: r 5 0.45, p , 0.05; M/L ratio–CCIMT: r 5
0.63, p , 0.01), without substantial changes in the level of
statistical significance.
No significant correlation was observed between morpho-
logic data (in particular, the M/L ratio in small resistance
arteries, LVMI and CCIMT) and systolic or diastolic arterial
pressure, age, plasma renin activity, PRA aldosterone, cat-
echolamines or other clinical factors. In particular, the corre-
lation coefficients between systolic and diastolic blood pressure
and morphologic findings were ,0.30 and were similar in the
different groups, although they were slightly weaker in the
patients with RVH (systolic blood pressure–M/L ratio in small
arteries: r 5 0.08).
Discussion
For the first time, to our knowledge, this study has exam-
ined the relation between cardiac and vascular structure in a
rather large group of patients with primary or secondary
hypertension, using direct, reliable and well assessed tech-
niques.
Extent of cardiovascular alterations. We have observed
that cardiac and vascular structural changes were more evident
in patients with RVH. It should be emphasized, however, that
an important, although not statistically significant trend toward
higher systolic and diastolic blood pressure was observed in
those patients with an increased activation of the renin-
Table 3. Correlation Coefficients Between Indexes of Cardiac and
Vascular Structure in the Different Groups
M/L Ratio vs.
CCIMT
M/L Ratio vs.
LVMI
CCIMT vs.
LVMI
All subjects 0.53* 0.44* 0.50*
Pheo 20.07 20.25 0.45
PA 0.43 0.50 0.19
RVH 0.74† 0.59† 0.74†
EH 0.02 0.20 0.21
NT 0.29 0.20 0.24
*p , 0.01. †p , 0.001. Statistical comparison of slopes and intercepts of
linear regression analysis; P values of significance of differences between RVH
and the other groups: M/L ratio–CCIMT vs. EH p 5 0.007, vs. NT p 5 0.001, vs.
Pheo p 5 0.0003. M/L ratio–LVMI vs. EH p 5 0.007, vs. NT p 5 0.003, vs. Pheo
p 5 0.0005.
Figure 1. Linear regression between M/L ratio and CCIMT in patients
with PA (solid triangles pointing down) and RVH (solid squares, solid
line) (top of figure) as well as in patients with pheochromocytoma
(solid triangles pointing up), EH (solid circles) and in NT control
subjects (open circles) (bottom of figure). See text for the number of
subjects in each group.
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angiotensin-aldosterone system. Therefore, it is not possible to
completely rule out a partial role of hemodynamic factors in
this observation. However, it seems reasonable that the
growth-promoting properties of the renin-angiotensin system
may account for a great part of the pronounced cardiovascular
changes observed. Circulatory renin has been demonstrated to
be correlated to clinical outcomes in hypertension (37), and
the possible link may be represented by alterations of the
cardiovascular structure.
Correlations between indexes of cardiovascular structure.
In the present study we have also demonstrated that a close
correlation between indexes of cardiac and vascular structure
could be observed in patients in whom the renin-angiotensin-
aldosterone system is activated, such as in those with RVH or,
to a lesser extent, those with PA. It is not possible, on an a
priori basis, to postulate which is the primary etiologic event in
the relations (i.e., whether small vessel changes may determine
cardiac or carotid changes or vice versa). An increased growth
factor activation (namely, angiotensin II in patients with RVH)
would stimulate, at the same time, different vascular and
cardiac targets. In patients with EH the level of growth factor
stimulation is probably too low to allow for the detection of a
clear-cut correlation, whereas in the other two groups of
patients with secondary hypertension, the growth factors in-
volved are probably less potent than angiotensin II. Another
possibility is represented by a synergistic action between
aldosterone and angiotensin II in patients with RVH. In a
previous study performed in patients with EH, a statistically
significant correlation between the M/L ratio of subcutaneous
small resistance arteries and LVMI was observed (38). How-
ever, if patients were subclassified according to the presence or
absence of LVH, the correlation was found only among
patients with LVH, but not in patients with normal left
ventricular mass or in NT control subjects (38). In the past
years, some studies have demonstrated the presence of an
association between carotid atherosclerotic lesions and LVH
(39,40). A correlation between carotid artery measures and left
ventricular mass was also observed in hypertensive patients
(41–43) and in general populations of NT and hypertensive
subjects (3,44,45), suggesting a parallel cardiac and vascular
adaptation in hypertension (46,47). However, the correlation
coefficients between indexes of cardiac and carotid artery
structure vary greatly among the different studies (from 0.20 to
0.49). In our study, a weak correlation between CCIMT and
LVMI was observed in patients with EH. Patients with EH can
hardly be considered a homogeneous group, because they
include patients with different pathophysiologic characteristics
(i.e., low, normal and high circulating levels of renin). It is
possible that a closer correlation between cardiac and vascular
structure could be observed in patients with EH with a more
pronounced activation of tissue or of the circulating renin-
angiotensin-aldosterone system, although in our study no
Figure 2. Linear regression between M/L ratio and LVMI in patients
with PA (solid triangles pointing down, dotted line) and RVH (solid
squares, solid line) (top of figure) as well as in patients with pheo-
chromocytoma (solid triangles pointing up), EH (solid circles) and in
NT control subjects (open circles) (bottom of figure). See text for the
number of subjects in each group.
Table 4. Incidence and Total Number of Atherosclerotic Plaques in
the Carotid Arteries
Patient Groups
Incidence of Plaques
(Percentage of
Subjects Having at
Least One Plaque)
Total Number of Plaques
in Each Group
Pheo (n 5 11) 64% 14
PA (n 5 12) 42% 6
RVH (n 5 14) 86% 31
EH (n 5 17) 65% 21
NT (n 5 11) 27% 3
Distribution of plaques—chi-square test: RVH vs. NT p 5 0.003; RVH vs.
PA p 5 0.02; NT vs. EH p 5 0.05. Total number of plaques—chi-square test:
RVH vs. EH p 5 0.036; RVH vs. NT p 5 0.00003; RVH vs. PA p 5 0.0003; Pheo
vs. PA p 5 0.047; Pheo vs. NT p 5 0.008; PA vs. EH p 5 0.04; NT vs. EH p 5
0.007. Abbreviations as in Table 1.
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significant correlation between plasma renin activity (PRA)
and cardiac mass, CCIMT or M/L ratio of small resistance
arteries could be observed, probably owing to the relatively low
reliability of PRA as an index of tissue renin-angiotensin-
aldosterone system activation. Changes in the vascular wall
might also be the consequence of compensatory neurohumoral
activation, secondary to a reduction in cardiac output possibly
present in patients with LVH, with consequent vasoconstric-
tion and growth stimulation. However, in our study cardiac
function was between normal limits in all patients. It is also
possible that the effects of angiotensin II on cardiovascular
structure could be mediated, at least in part, by a stimulation of
endothelin-1 (48), which was demonstrated to possess growth-
promoting properties. It cannot, however, be excluded that
additional neurohumoral factors, beside angiotensin II,
endothelin-1 and aldosterone, may have influenced vascular
growth. Although no significant correlation between blood pres-
sure and vascular structure was observed in any group, the
observation of a particularly weak correlation in patients with
RVH (compared with relatively strong correlations between
indexes of cardiac and vascular structure) strengthens our argu-
ment about the importance of growth factor activation rather
than blood pressure alone.
Carotid plaques. In our group of patients with RVH and,
to a lesser extent, with pheochromocytoma, a higher preva-
lence of atherosclerotic lesions in the common carotid artery
was detected. It is possible that the humoral determinants of
the vessel wall remodeling and of the development of athero-
sclerotic plaques may be partially different. Nevertheless, in
the common carotid artery of patients with RVH a greater
incidence of both vascular plaque and media hypertrophy seems
to be present. This finding could also have clinical importance, as
suggested by the observation of an association between the
renin-angiotensin system and hypertensive cerebrovascular dis-
ease (37,49). It is possible, however, that structural alterations in
the common carotid artery may be associated with an abnormality
in compliance of large arteries, and subsequently to an elevation
of resistance to cardiac output ejection from the left ventricle,
which may increase the stress on the heart, thus leading to LVH
(50). In addition, it is also possible that concomitant atheroscle-
rotic disease may be present in coronary arteries, with consequent
ischemia triggering changes in the myocardium and compensa-
tory ventricular hypertrophy. However, in our study, no clinical,
electrocardiographic or echocardiographic sign of myocardial
ischemia was present in any patients.
Cardiac mass in PA. In previous studies, an increase in
LVMI was observed in patients with PA as compared with
those with EH (14,15). In our group of patients, we observed
only a small increase in wall thickness. A possible explanation
of these conflicting findings could be a different duration of
hypertension or a slightly lower prevalence of females in our
study. However, our data clearly indicate that for the same
duration and severity of hypertension, patients with PA have
fewer cardiac structural changes than do patients with RVH. In
our study and in that of Rossi et al. (15), no signs of left
ventricular enlargement were observed, whereas in the study of
Shigematsu et al. (14), a modest increase in left ventricular
end-diastolic dimension index was detected. Several publica-
tions have demonstrated the presence of fibrotic changes in the
myocardium of patients with PA (51,52). Although these
fibrotic changes may lead to some abnormalities in left ven-
tricular compliance and relaxation, left ventricular mass may
not necessarily be increased.
Cardiac mass in pheochromocytoma. In our study the
pattern of cardiovascular alterations in patients with pheochro-
mocytoma was similar to that observed in patients with EH,
despite the fact that catecholamines seem to have growth-
promoting properties in vitro (7,53,54). Our findings are in
agreement with previous observations; in fact, left ventricular
mass seems to not necessarily be higher in patients with
pheochromocytoma, as compared with patients with EH and
equivalent blood pressure levels (9,16). It is therefore possible
that these in vitro observations (53,54) may hardly be extrap-
olated to the clinical setting.
Clinical implications. Our findings may have important
clinical implications. If a relevant role of the circulating or
tissue renin-angiotensin-aldosterone system in the simulta-
neous development of cardiac and vascular structural alter-
ations is accepted, then it is advisable to look for the presence
of alterations both at the cardiac and at different vascular levels
when an excessive stimulation of this system occurs. In addi-
tion, from a therapeutic point of view, our data suggest that
drugs which can reduce the renin-angiotensin-aldosterone
system activity may be particularly advantageous in those
situations where pronounced cardiovascular structural alter-
ations are present at the same time. These points should be
further evaluated and clarified in the future.
Conclusions. Cardiac and vascular structural changes were
more evident in patients with RVH. A close relation between
small resistance artery morphology and cardiac or carotid
artery structure may be observed in those patients in whom the
renin-angiotensin-aldosterone system is activated. In contrast,
in patients with EH or pheochromocytoma or in NT control
subjects, no significant correlation between the M/L ratio and
LVMI or CCIMT was observed.
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